Text Size
37 studies found for:    " March 30, 2011":" April 29, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]

Modify this search | How to Use Search Results

Show Display Options
RSS Create an RSS feed from your search for:
" March 30, 2011":" April 29, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
2 Withdrawn A Safety and Efficacy Trial of Dapivirine Vaginal Ring in Africa
Condition: HIV Infections
Interventions: Other: Dapivirine;   Other: Placebo;   Drug: Dapivirine
3 Not yet recruiting Text Messaging Intervention to Improve HIV Adherence in Rural Drug Users
Condition: HIV Infections
Interventions: Behavioral: Text messaging plus EMA;   Behavioral: Treatment as usual
4 Active, not recruiting Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Strategy
Condition: HIV Disease
Interventions: Drug: HAART regimen;   Drug: 3TC or FTC monotherapy
5 Unknown † Improving Antiretroviral Medication Adherence Among HIV-infected Youth
Condition: HIV Infection
Intervention: Behavioral: Positive STEPS
6 Completed
Has Results 		Clinical Study of TUTI-16 in Asymptomatic HIV-1 Infected Subjects (THYMON-11001)
Condition: HIV Infections
Interventions: Biological: TUTI-16 (1.0 mg);   Other: Placebo
7 Recruiting Efficacy and Safety of Two Pharmacologic Strategies on Neurocognitive Impairment in HIV Infection. The TRIANT-TE Study
Conditions: Neurocognitive Disturbance;   HIV Infection
Interventions: Drug: Lithium;   Drug: Rivastigmine
8 Active, not recruiting Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)
Conditions: HIV Infection;   Substance Abuse
Interventions: Behavioral: empowerment theory-based small group discussion;   Behavioral: individual resilience counseling
9 Active, not recruiting The Study of Gut Associated Lymphocytes in HIV and HCV/HIV Co-infected Patients
Conditions: HIV;   Hepatitis C;   HIV and Hepatitis C Coinfection
Intervention:
10 Active, not recruiting Efficacy, Safety, and Tolerability of Cenicriviroc (CVC) in Combination With Truvada or Sustiva Plus Truvada in HIV 1-infected, Antiretroviral Treatment-naïve, Adult Patients Infected With Only CCR5-tropic Virus
Condition: HIV-1 Infection
Interventions: Drug: Cenicriviroc 100 mg;   Drug: Cenicriviroc 200 mg + Truvada;   Drug: Sustiva + Truvada
11 Completed A Study to Investigate the Pharmacokinetics, Safety and Tolerability of GSK1349572 (Dolutegravir, DTG) in Healthy Japanese Subjects
Condition: Infection, Human Immunodeficiency Virus
Intervention: Drug: GSK1349572
12 Not yet recruiting Effect of a Non-tenofovir, Non-efavirenz-based HIV Regimen on Bone Density and Vitamin D Levels in African-American Patients With HIV Infection
Condition: HIV
Interventions: Drug: atripla;   Drug: darunavir ritonavir raltegravir
13 Recruiting Phase IIIB Pediatric ATV Powder for Oral Use (POU) (PRINCE2)
Condition: HIV
Interventions: Drug: Atazanavir Sulphate;   Drug: Ritonavir
14 Active, not recruiting Drug Use Investigation of Kaletra Tablets (Once Daily Administration) on Patients With HIV-infection
Condition: Human Immunodeficiency Virus Infection
Intervention:
15 Recruiting Human Immune Responses Toward HIV-1 Envelope Antigens
Condition: HIV Infection
Intervention:
16 Active, not recruiting Clinical Trial of Brain-Penetrating HIV Drugs to Prevent Cognitive Impairment in China
Conditions: HIV Infections;   Central Nervous System Diseases;   Dementia
Interventions: Drug: zidovudine-lamivudine-nevirapine;   Drug: tenofovir-lamivudine-efavirenz
17 Recruiting Microparticles, Vector of Genetic Information During HIV Infection
Condition: HIV,
Intervention: Biological: Blood samples
18 Completed Drug Drug Interaction of BI 201335 and Tenofovir
Condition: HIV Infections
Intervention: Drug: tenofovir/BI 201335
19 Completed Role of HIV on Glutathione Synthesis and Oxidative Stress
Conditions: HIV Infection;   Erythrocyte Glutathione Deficiency
Interventions: Dietary Supplement: Cysteine (as n-acetylcysteine) and glycine;   Dietary Supplement: Cysteine/glycine
20 Recruiting Veliparib, Bendamustine Hydrochloride, and Rituximab in Treating Patients With Advanced Lymphoma, Multiple Myeloma, or Solid Tumors
Conditions: AIDS-related Diffuse Large Cell Lymphoma;   AIDS-related Diffuse Mixed Cell Lymphoma;   AIDS-related Diffuse Small Cleaved Cell Lymphoma;   AIDS-related Immunoblastic Large Cell Lymphoma;   AIDS-related Lymphoblastic Lymphoma;   AIDS-related Peripheral/Systemic Lymphoma;   AIDS-related Small Noncleaved Cell Lymphoma;   Anaplastic Large Cell Lymphoma;   Angioimmunoblastic T-cell Lymphoma;   Cutaneous B-cell Non-Hodgkin Lymphoma;   Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue;   Hepatosplenic T-cell Lymphoma;   HIV-associated Hodgkin Lymphoma;   Nodal Marginal Zone B-cell Lymphoma;   Noncutaneous Extranodal Lymphoma;   Peripheral T-cell Lymphoma;   Recurrent Adult Burkitt Lymphoma;   Recurrent Adult Diffuse Large Cell Lymphoma;   Recurrent Adult Diffuse Mixed Cell Lymphoma;   Recurrent Adult Diffuse Small Cleaved Cell Lymphoma;   Recurrent Adult Grade III Lymphomatoid Granulomatosis;   Recurrent Adult Hodgkin Lymphoma;   Recurrent Adult Immunoblastic Large Cell Lymphoma;   Recurrent Adult Lymphoblastic Lymphoma;   Recurrent Adult T-cell Leukemia/Lymphoma;   Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma;   Recurrent Grade 1 Follicular Lymphoma;   Recurrent Grade 2 Follicular Lymphoma;   Recurrent Grade 3 Follicular Lymphoma;   Recurrent Grade I Lymphomatoid Granulomatosis;   Recurrent Grade II Lymphomatoid Granulomatosis;   Recurrent Mantle Cell Lymphoma;   Recurrent Marginal Zone Lymphoma;   Recurrent Small Lymphocytic Lymphoma;   Refractory Multiple Myeloma;   Small Intestine Lymphoma;   Splenic Marginal Zone Lymphoma;   Unspecified Adult Solid Tumor, Protocol Specific
Interventions: Drug: bendamustine hydrochloride;   Drug: veliparib;   Other: diagnostic laboratory biomarker analysis;   Other: pharmacological study;   Biological: rituximab
To Top

Previous Page Studies Shown (1-20) Next Page (21-37) Show next page of results
† Indicates status has not been verified in more than two years